OTC Stannous Fluoride Toothpaste Centers Prevention, Not Rescue
The DailyMed label for ARU GUM HEALTH positions the product as an everyday preventive oral care intervention rather than a treatment for established dental disease. Its active ingredient is stannous fluoride 0.454%, delivering 0.15% fluoride ion, and the stated purpose is straightforward: anticavity and antigingivitis. In practical terms, the formulation is built for two common, overlapping problems in routine dentistry—mineral loss from acid exposure and inflammatory changes at the gingival margin driven by plaque accumulation.
A fluoride dentifrice works best when it is used consistently, and this label leans hard into that model. Adults and children 3 years and older are instructed to brush thoroughly after meals or at least twice daily, or to follow a dentist’s directions. The instructions also stress not to swallow the paste, a reminder that oral benefit depends on local exposure on the tooth surface rather than systemic ingestion. In children, the margin between benefit and avoidable exposure is narrower, which is why supervision and age-specific dosing appear directly in the directions.
Fluoride Chemistry Meets Plaque Biology
Stannous fluoride occupies a familiar place in preventive dentistry because it does more than simply bathe enamel in fluoride. The fluoride ion supports remineralization and helps harden vulnerable tooth surfaces, while the stannous component has long been associated with suppression of plaque-related processes that drive gingival irritation. In this label, the clinical promise is compact but meaningful: aid in the prevention of cavities, help prevent gingivitis, help control plaque bacteria that contribute to gingivitis, and help interfere with the harmful effects of plaque associated with gingivitis.
That combination matters because caries and gingivitis often travel together in real-world oral hygiene. Plaque is not just a cosmetic film; it is a biologically active biofilm that creates a low-grade inflammatory environment at the gumline and sets the stage for enamel demineralization when acids accumulate. A dentifrice that addresses both sides of that problem offers a rational preventive strategy, especially for patients whose daily oral care is inconsistent or who already show early signs of gingival inflammation.
The formulation also includes inactive ingredients that support texture, foaming, flavor, and shelf stability: sorbitol, silica, water, cocamidopropyl betaine, carboxymethylcellulose sodium, potassium sorbate, and stevia rebaudiana leaf extract. Mint flavor is listed, which is not a trivial detail in preventive adherence; a toothpaste that patients will actually use twice a day is more likely to deliver the intended local fluoride exposure.
Safety Language Is Minimal, Direct, and Pediatric-Focused
The label’s safety instructions are brief because the product sits in the OTC preventive category, but they are clinically important. Children under 6 years of age should keep the paste out of reach, and if more than used for brushing is swallowed, professional help or Poison Control should be contacted immediately. For children under 6, the recommended strategy is a pea-sized amount with supervision of brushing and rinsing until good habits are established. Children under 2 years should be evaluated by a dentist or doctor before use.
A single sentence on staining stands out because it reflects a common counseling point in dental practice. Products containing stannous fluoride may produce surface staining of the teeth, but adequate toothbrushing may prevent these stains, which are not harmful or permanent and may be removed by a dentist. The staining issue is cosmetic, not structural, yet it can affect acceptance if patients are not warned in advance. Framing that risk honestly helps prevent unnecessary discontinuation of a product that may otherwise be useful for both caries and gingival control.
The warning to avoid swallowing is especially relevant in younger children, where toothpaste ingestion can become routine if brushing is unsupervised. The label does not add complexity beyond that basic principle, and it does not need to. Prevention in this setting depends on dose discipline, parental oversight, and routine use rather than escalation to higher-strength intervention.
Monograph Positioning and Marketed Formulation Details
This product is classified as a human OTC drug under OTC Monograph Drug M021, with dental route administration and no DEA schedule. The active ingredient strength is listed in the product information as 0.11 g in 100 g of stannous fluoride, which corresponds to the labeled percentage strength. The package description identifies a 99 g tube in a single-box presentation, and the labeler is Ashtel Studios, Inc.
The updated label date is October 8, 2026, and the DailyMed version history shows the current published version as October 19, 2026. For clinicians, pharmacists, and caregivers, those dates mainly matter as a marker that the product has a current federal label framework and a clearly specified set of instructions, warnings, and ingredients. The marketing information lists a start date of January 12, 2026, with a projected end date of April 30, 2028, though the clinical use case itself is unchanged by those administrative markers.
What This Means at the Sink, Not in the Exam Room
For dental prevention, the real-world value of a toothpaste like this is mundane and substantial. A product with fluoride, plaque-directed action, and child-specific dosing instructions can fit into the daily habits that shape long-term oral health far more often than episodic dental rescue measures do. The chemistry is simple. The clinical target is not.
When brushing is twice daily, supervised in young children, and paired with reasonable expectations about staining and swallowing risk, the product serves the narrow preventive role its label defines. If those conditions are not met, the benefit shrinks quickly. This is one of the clearest examples in oral care where adherence, technique, and age-appropriate supervision decide whether a labeled preventive can do its job.
The remaining uncertainty is not about whether fluoride can help teeth or whether plaque control matters. It is whether households consistently apply the directions with enough discipline to convert a labeled anticavity, antigingivitis toothpaste into a durable habit that actually changes daily oral exposure.